ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Efficacy and safety of BTK inhibitor combined with bendamustine and rituximab in the first-line treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma].

S C Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.